Logo image of LH

LABCORP HOLDINGS INC (LH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LH - US5049221055 - Common Stock

251.81 USD
-2.86 (-1.12%)
Last: 1/9/2026, 8:04:00 PM
251.81 USD
0 (0%)
After Hours: 1/9/2026, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, LH scores 5 out of 10 in our fundamental rating. LH was compared to 100 industry peers in the Health Care Providers & Services industry. LH has only an average score on both its financial health and profitability. LH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

LH had positive earnings in the past year.
LH had a positive operating cash flow in the past year.
In the past 5 years LH has always been profitable.
Each year in the past 5 years LH had a positive operating cash flow.
LH Yearly Net Income VS EBIT VS OCF VS FCFLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

LH's Return On Assets of 4.68% is fine compared to the rest of the industry. LH outperforms 75.25% of its industry peers.
LH has a better Return On Equity (9.83%) than 71.29% of its industry peers.
The Return On Invested Capital of LH (6.32%) is better than 63.37% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LH is below the industry average of 9.19%.
The last Return On Invested Capital (6.32%) for LH is above the 3 year average (6.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.68%
ROE 9.83%
ROIC 6.32%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
LH Yearly ROA, ROE, ROICLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 6.21%, LH belongs to the top of the industry, outperforming 83.17% of the companies in the same industry.
In the last couple of years the Profit Margin of LH has declined.
Looking at the Operating Margin, with a value of 9.92%, LH is in the better half of the industry, outperforming 79.21% of the companies in the same industry.
In the last couple of years the Operating Margin of LH has declined.
LH has a Gross Margin of 28.45%. This is comparable to the rest of the industry: LH outperforms 57.43% of its industry peers.
In the last couple of years the Gross Margin of LH has remained more or less at the same level.
Industry RankSector Rank
OM 9.92%
PM (TTM) 6.21%
GM 28.45%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
LH Yearly Profit, Operating, Gross MarginsLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LH is destroying value.
The number of shares outstanding for LH has been reduced compared to 1 year ago.
LH has less shares outstanding than it did 5 years ago.
The debt/assets ratio for LH is higher compared to a year ago.
LH Yearly Shares OutstandingLH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LH Yearly Total Debt VS Total AssetsLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

LH has an Altman-Z score of 3.07. This indicates that LH is financially healthy and has little risk of bankruptcy at the moment.
LH has a better Altman-Z score (3.07) than 64.36% of its industry peers.
The Debt to FCF ratio of LH is 4.09, which is a neutral value as it means it would take LH, 4.09 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.09, LH is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that LH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.59, LH perfoms like the industry average, outperforming 58.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.09
Altman-Z 3.07
ROIC/WACC0.76
WACC8.34%
LH Yearly LT Debt VS Equity VS FCFLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

LH has a Current Ratio of 1.55. This is a normal value and indicates that LH is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.55, LH perfoms like the industry average, outperforming 58.42% of the companies in the same industry.
A Quick Ratio of 1.35 indicates that LH should not have too much problems paying its short term obligations.
LH has a Quick ratio (1.35) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.35
LH Yearly Current Assets VS Current LiabilitesLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.71% over the past year.
Measured over the past 5 years, LH shows a small growth in Earnings Per Share. The EPS has been growing by 5.20% on average per year.
LH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.28%.
The Revenue has been growing slightly by 2.40% on average over the past years.
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%

3.2 Future

Based on estimates for the next years, LH will show a small growth in Earnings Per Share. The EPS will grow by 7.93% on average per year.
The Revenue is expected to grow by 4.05% on average over the next years.
EPS Next Y15.41%
EPS Next 2Y11.22%
EPS Next 3Y10.7%
EPS Next 5Y7.93%
Revenue Next Year7.76%
Revenue Next 2Y6.07%
Revenue Next 3Y5.66%
Revenue Next 5Y4.05%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LH Yearly Revenue VS EstimatesLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
LH Yearly EPS VS EstimatesLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

6

4. Valuation

4.1 Price/Earnings Ratio

LH is valuated correctly with a Price/Earnings ratio of 15.92.
82.18% of the companies in the same industry are more expensive than LH, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.19, LH is valued a bit cheaper.
With a Price/Forward Earnings ratio of 13.97, LH is valued correctly.
Based on the Price/Forward Earnings ratio, LH is valued cheaply inside the industry as 80.20% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.92, LH is valued a bit cheaper.
Industry RankSector Rank
PE 15.92
Fwd PE 13.97
LH Price Earnings VS Forward Price EarningsLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LH is valued a bit cheaper than the industry average as 62.38% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, LH is valued a bit cheaper than the industry average as 74.26% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.12
EV/EBITDA 13.6
LH Per share dataLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

LH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of LH may justify a higher PE ratio.
PEG (NY)1.03
PEG (5Y)3.06
EPS Next 2Y11.22%
EPS Next 3Y10.7%

5

5. Dividend

5.1 Amount

LH has a Yearly Dividend Yield of 1.13%. Purely for dividend investing, there may be better candidates out there.
LH's Dividend Yield is rather good when compared to the industry average which is at 0.59. LH pays more dividend than 86.14% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, LH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

On average, the dividend of LH grows each year by 96.38%, which is quite nice.
LH has been paying a dividend for over 5 years, so it has already some track record.
LH has decreased its dividend in the last 3 years.
Dividend Growth(5Y)96.38%
Div Incr Years2
Div Non Decr Years2
LH Yearly Dividends per shareLH Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 1 2 3

5.3 Sustainability

28.24% of the earnings are spent on dividend by LH. This is a low number and sustainable payout ratio.
The dividend of LH is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.24%
EPS Next 2Y11.22%
EPS Next 3Y10.7%
LH Yearly Income VS Free CF VS DividendLH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
LH Dividend Payout.LH Dividend Payout, showing the Payout Ratio.LH Dividend Payout.PayoutRetained Earnings

LABCORP HOLDINGS INC

NYSE:LH (1/9/2026, 8:04:00 PM)

After market: 251.81 0 (0%)

251.81

-2.86 (-1.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-05 2026-02-05
Inst Owners98.13%
Inst Owner Change-0.72%
Ins Owners0.31%
Ins Owner Change-2.44%
Market Cap20.88B
Revenue(TTM)13.77B
Net Income(TTM)855.20M
Analysts82.76
Price Target305.75 (21.42%)
Short Float %3.82%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend2.91
Dividend Growth(5Y)96.38%
DP28.24%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.25%
Min EPS beat(2)-1.84%
Max EPS beat(2)1.34%
EPS beat(4)1
Avg EPS beat(4)-0.49%
Min EPS beat(4)-1.84%
Max EPS beat(4)1.34%
EPS beat(8)3
Avg EPS beat(8)-0.27%
EPS beat(12)4
Avg EPS beat(12)-0.63%
EPS beat(16)6
Avg EPS beat(16)0.3%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-2.8%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-2.81%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-2.35%
Revenue beat(12)0
Avg Revenue beat(12)-5.86%
Revenue beat(16)0
Avg Revenue beat(16)-13.64%
PT rev (1m)0%
PT rev (3m)1.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.98%
EPS NY rev (1m)0%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 15.92
Fwd PE 13.97
P/S 1.52
P/FCF 15.12
P/OCF 11.57
P/B 2.4
P/tB N/A
EV/EBITDA 13.6
EPS(TTM)15.82
EY6.28%
EPS(NY)18.02
Fwd EY7.16%
FCF(TTM)16.66
FCFY6.61%
OCF(TTM)21.76
OCFY8.64%
SpS166.05
BVpS104.91
TBVpS-18.78
PEG (NY)1.03
PEG (5Y)3.06
Graham Number193.24
Profitability
Industry RankSector Rank
ROA 4.68%
ROE 9.83%
ROCE 8.73%
ROIC 6.32%
ROICexc 6.57%
ROICexgc 20.66%
OM 9.92%
PM (TTM) 6.21%
GM 28.45%
FCFM 10.03%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
ROICexc(3y)6.66%
ROICexc(5y)9.53%
ROICexgc(3y)24.5%
ROICexgc(5y)35.7%
ROCE(3y)8.72%
ROCE(5y)12.25%
ROICexgc growth 3Y-23.52%
ROICexgc growth 5Y-8.03%
ROICexc growth 3Y-23.85%
ROICexc growth 5Y-3.15%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
F-Score9
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.09
Debt/EBITDA 2.7
Cap/Depr 77.99%
Cap/Sales 3.07%
Interest Coverage 5.52
Cash Conversion 94.58%
Profit Quality 161.46%
Current Ratio 1.55
Quick Ratio 1.35
Altman-Z 3.07
F-Score9
WACC8.34%
ROIC/WACC0.76
Cap/Depr(3y)76.91%
Cap/Depr(5y)70.72%
Cap/Sales(3y)3.85%
Cap/Sales(5y)3.56%
Profit Quality(3y)157.09%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
EPS Next Y15.41%
EPS Next 2Y11.22%
EPS Next 3Y10.7%
EPS Next 5Y7.93%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%
Revenue Next Year7.76%
Revenue Next 2Y6.07%
Revenue Next 3Y5.66%
Revenue Next 5Y4.05%
EBIT growth 1Y20.09%
EBIT growth 3Y-28.19%
EBIT growth 5Y-5.19%
EBIT Next Year32.28%
EBIT Next 3Y13.96%
EBIT Next 5Y12.85%
FCF growth 1Y38.44%
FCF growth 3Y-25.49%
FCF growth 5Y0.97%
OCF growth 1Y28.67%
OCF growth 3Y-20.11%
OCF growth 5Y1.88%

LABCORP HOLDINGS INC / LH FAQ

What is the ChartMill fundamental rating of LABCORP HOLDINGS INC (LH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to LH.


What is the valuation status for LH stock?

ChartMill assigns a valuation rating of 6 / 10 to LABCORP HOLDINGS INC (LH). This can be considered as Fairly Valued.


What is the profitability of LH stock?

LABCORP HOLDINGS INC (LH) has a profitability rating of 6 / 10.


What is the valuation of LABCORP HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LABCORP HOLDINGS INC (LH) is 15.92 and the Price/Book (PB) ratio is 2.4.


What is the expected EPS growth for LABCORP HOLDINGS INC (LH) stock?

The Earnings per Share (EPS) of LABCORP HOLDINGS INC (LH) is expected to grow by 15.41% in the next year.